PNC Financial Services Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.08M | Sell |
12,322
-356
| -3% | -$121K | ﹤0.01% | 761 |
|
|
2025
Q4 | $5.04M | Sell |
12,678
-437
| -3% | -$193K | ﹤0.01% | 713 |
|
|
2025
Q3 | $5.98M | Sell |
13,115
-55
| -0.4% | -$22.4K | ﹤0.01% | 661 |
|
|
2025
Q2 | $4.29M | Buy |
13,170
+45
| +0.3% | +$12.5K | ﹤0.01% | 724 |
|
|
2025
Q1 | $3.54M | Buy |
13,125
+585
| +5% | +$150K | ﹤0.01% | 747 |
|
|
2024
Q4 | $2.95M | Sell |
12,540
-3
| -0% | -$789 | ﹤0.01% | 802 |
|
|
2024
Q3 | $3.45M | Buy |
12,543
+144
| +1% | +$37.5K | ﹤0.01% | 761 |
|
|
2024
Q2 | $3.01M | Buy |
12,399
+212
| +2% | +$33.5K | ﹤0.01% | 774 |
|
|
2024
Q1 | $1.82M | Sell |
12,187
-931
| -7% | -$155K | ﹤0.01% | 938 |
|
|
2023
Q4 | $2.51M | Sell |
13,118
-2,547
| -16% | -$434K | ﹤0.01% | 816 |
|
|
2023
Q3 | $2.77M | Sell |
15,665
-39
| -0.2% | -$7.44K | ﹤0.01% | 766 |
|
|
2023
Q2 | $2.98M | Buy |
15,704
+96
| +0.6% | +$19K | ﹤0.01% | 773 |
|
|
2023
Q1 | $3.13M | Buy |
15,608
+25
| +0.2% | +$5.25K | ﹤0.01% | 756 |
|
|
2022
Q4 | $3.7M | Sell |
15,583
-214
| -1% | -$45.6K | ﹤0.01% | 699 |
|
|
2022
Q3 | $3.16M | Sell |
15,797
-559
| -3% | -$107K | ﹤0.01% | 727 |
|
|
2022
Q2 | $2.39M | Buy |
16,356
+846
| +5% | +$120K | ﹤0.01% | 831 |
|
|
2022
Q1 | $2.53M | Buy |
15,510
+1
| +0% | +$152 | ﹤0.01% | 871 |
|
|
2021
Q4 | $2.63M | Buy |
15,509
+6
| +0% | +$1.11K | ﹤0.01% | 875 |
|
|
2021
Q3 | $2.93M | Sell |
15,503
-499
| -3% | -$93.6K | ﹤0.01% | 796 |
|
|
2021
Q2 | $2.71M | Buy |
16,002
+107
| +0.7% | +$15.7K | ﹤0.01% | 823 |
|
|
2021
Q1 | $2.25M | Buy |
15,895
+1,504
| +10% | +$226K | ﹤0.01% | 838 |
|
|
2020
Q4 | $1.87M | Buy |
14,391
+8,321
| +137% | +$1.11M | ﹤0.01% | 862 |
|
|
2020
Q3 | $883K | Sell |
6,070
-779
| -11% | -$111K | ﹤0.01% | 1092 |
|
|
2020
Q2 | $1.01M | Sell |
6,849
-6,433
| -48% | -$867K | ﹤0.01% | 1034 |
|
|
2020
Q1 | $1.45M | Buy |
13,282
+4,262
| +47% | +$492K | ﹤0.01% | 831 |
|
|
2019
Q4 | $1.04M | Buy |
9,020
+57
| +0.6% | +$5.68K | ﹤0.01% | 1079 |
|
|
2019
Q3 | $721K | Buy |
8,963
+84
| +0.9% | +$6.64K | ﹤0.01% | 1403 |
|
|
2019
Q2 | $643K | Buy |
8,879
+108
| +1% | +$8.29K | ﹤0.01% | 1485 |
|
|
2019
Q1 | $820K | Buy |
8,771
+55
| +0.6% | +$4.6K | ﹤0.01% | 1377 |
|
|
2018
Q4 | $635K | Buy |
8,716
+55
| +0.6% | +$4.23K | ﹤0.01% | 1439 |
|
|
2018
Q3 | $758K | Buy |
8,661
+6
| +0.1% | +$604 | ﹤0.01% | 1458 |
|
|
2018
Q2 | $852K | Sell |
8,655
-193
| -2% | -$19.1K | ﹤0.01% | 1394 |
|
|
2018
Q1 | $1.05M | Sell |
8,848
-16
| -0.2% | -$2.06K | ﹤0.01% | 1295 |
|
|
2017
Q4 | $1.13M | Buy |
8,864
+65
| +0.7% | +$8.17K | ﹤0.01% | 1269 |
|
|
2017
Q3 | $1.03M | Sell |
8,799
-471
| -5% | -$40.2K | ﹤0.01% | 1279 |
|
|
2017
Q2 | $739K | Buy |
9,270
+585
| +7% | +$37.4K | ﹤0.01% | 1415 |
|
|
2017
Q1 | $446K | Buy |
8,685
+36
| +0.4% | +$1.66K | ﹤0.01% | 1685 |
|
|
2016
Q4 | $322K | Sell |
8,649
-128
| -1% | -$5.36K | ﹤0.01% | 1844 |
|
|
2016
Q3 | $595K | Hold |
8,777
| – | – | ﹤0.01% | 1477 |
|
|
2016
Q2 | $487K | Buy |
8,777
+464
| +6% | +$29.2K | ﹤0.01% | 1562 |
|
|
2016
Q1 | $523K | Hold |
8,313
| – | – | ﹤0.01% | 1525 |
|
|
2015
Q4 | $782K | Buy |
+8,313
| New | +$771K | ﹤0.01% | 1312 |
|
|
2014
Q4 | – | Sell |
-177
| Closed | -$14K | – | 4147 |
|
|
2014
Q3 | $14K | Hold |
177
| – | – | ﹤0.01% | 3166 |
|
|
2014
Q2 | $11K | Hold |
177
| – | – | ﹤0.01% | 3108 |
|
|
2014
Q1 | $12K | Buy |
+177
| New | +$13.7K | ﹤0.01% | 2998 |
|
Other funds holding ALNY
VPM
VCM
